Exudative macular degeneration - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Exudative (Wet) Macular Degeneration – Complete Medical Guide

Exudative (Wet) Macular Degeneration – A Comprehensive Medical Guide

Overview

Exudative macular degeneration, more commonly known as **wet age‑related macular degeneration (AMD)**, is a progressive eye disease that damages the macula—the central portion of the retina responsible for sharp, detailed vision. Unlike the “dry” form, wet AMD is characterized by the growth of abnormal blood vessels beneath the retina that leak fluid or blood, leading to rapid vision loss if left untreated.

While AMD primarily affects older adults, it is the leading cause of irreversible central vision loss in people over age 60 in the United States and many other high‑income countries.[1] It accounts for roughly 10‑15 % of all AMD cases, yet it is responsible for about 80 % of the severe vision loss associated with the disease.[2]

Prevalence

  • In the U.S., an estimated 2.8 million people have wet AMD (≈1.3 % of adults ≥40 years).[3]
  • Globally, the World Health Organization estimates > 200 million people have some form of AMD; wet AMD comprises roughly 10‑15 % of those cases.[4]
  • Risk rises sharply after age 60; prevalence doubles approximately every five years thereafter.

Symptoms

Symptoms often develop quickly—over days to weeks—compared with the gradual changes seen in dry AMD. Anyone experiencing the following should obtain an eye exam promptly.

  • Blurry or distorted central vision (straight lines may appear wavy—called metamorphopsia).
  • Dark or empty spots in the center of the visual field.
  • Reduced color perception, making colors look faded.
  • Difficulty reading or recognizing faces, especially under low‑light conditions.
  • Rapid loss of visual acuity that cannot be corrected with glasses.
  • Seeing straight lines as bent or crooked (e.g., grid lines on a page).
  • Flashing lights or sudden onset of floaters (may indicate hemorrhage).
  • Reduced contrast sensitivity, making it hard to distinguish objects that are similar in shade.

Causes and Risk Factors

Wet AMD results from a complex interplay of genetic, environmental, and systemic factors that drive the formation of choroidal neovascularization (CNV).

Primary Pathophysiology

  • Age‑related degeneration of the retinal pigment epithelium (RPE) and Bruch’s membrane.
  • Hypoxia and oxidative stress trigger over‑production of vascular endothelial growth factor (VEGF), a protein that promotes new blood‑vessel growth.
  • These new vessels are fragile, leak fluid, and can bleed into the retina, causing scar tissue that destroys photoreceptors.

Key Risk Factors

  • Age: Risk rises dramatically after 60 years; > 90 % of cases are ≥ 65.
  • Genetics: Variants in the CFH, ARMS2, and HTRA1 genes increase susceptibility. A first‑degree relative with AMD doubles the risk.[5]
  • Smoking: Current smokers have a 2‑3× higher risk; former smokers retain an elevated risk for many years.[6]
  • Race/Ethnicity: Higher prevalence in Caucasians; lower in African‑American and Asian populations.
  • Cardiovascular disease & hypertension: Atherosclerosis and high blood pressure are linked to VEGF elevation.
  • Obesity & high‑fat diet: Associated with systemic inflammation that may accelerate retinal degeneration.
  • Exposure to sunlight (UV‑A/B) without protection: Cumulative phototoxic damage.
  • Certain medications: Long‑term use of photosensitizing drugs (e.g., thiazide diuretics, certain antibiotics) may increase risk.

Diagnosis

Early detection is essential because treatment can stabilize or improve vision in many patients.

Clinical Examination

  • Visual acuity test: Determines baseline central vision.
  • Amsler grid: Simple home‑based tool to detect metamorphopsia.
  • Dilated fundus examination: Ophthalmologist inspects the retina with a slit‑lamp and binocular indirect ophthalmoscope.

Imaging Modalities

  • Optical Coherence Tomography (OCT): Non‑invasive cross‑sectional imaging that reveals fluid accumulation, retinal thickening, and the presence of CNV.
  • Fluorescein Angiography (FA): Intravenous dye highlights leaking vessels, confirming active wet AMD.
  • Indocyanine Green Angiography (ICGA): Better visualizes deeper choroidal vessels, useful in atypical cases.
  • Fundus Autofluorescence (FAF):** Detects metabolic changes in the RPE before clinical signs appear.

Diagnosis is confirmed when imaging shows sub‑retinal fluid, pigment epithelial detachment, or clearly visible CNV consistent with wet AMD.

Treatment Options

Current therapies focus on **inhibiting VEGF**, controlling leakage, and preserving vision. Treatment is individualized based on disease activity, lesion size, and patient health.

Anti‑VEGF Intravitreal Injections

  • Ranibizumab (Lucentis) – FDA‑approved for wet AMD; typically 1‑month loading phase followed by monthly or PRN (as‑needed) dosing.
  • Aflibercept (Eylea) – Binds VEGF‑A, VEGF‑B, and PlGF; dosing can be every 8 weeks after an initial series.
  • Bevacizumab (Avastin) – Off‑label but widely used; cost‑effective, similar efficacy in many studies.
  • Brolucizumab (Beovu) – Longer dosing interval (12 weeks) for some patients; watch for rare intra‑ocular inflammation.

Clinical trials demonstrate that regular anti‑VEGF therapy can maintain or improve vision in **≈30‑40 %** of patients and prevent severe loss in > 90 % when started early.[7]

Photodynamic Therapy (PDT)

Older standard: verteporfin (Visudyne) is injected, then a low‑intensity laser activates the drug, selectively sealing abnormal vessels. PDT is now reserved for polypoidal choroidal vasculopathy or cases refractory to anti‑VEGF.

Laser Photocoagulation

Direct thermal laser can seal leaking vessels but risks damaging surrounding retina; limited to extrafoveal lesions.

Surgical Options

  • Sub‑macular surgery: Rarely performed; removes scar tissue after chronic CNV.
  • Vitrectomy: May be indicated for massive vitreous hemorrhage.

Adjunctive Lifestyle & Nutritional Measures

  • AREDS2 supplementation: High‑dose vitamin C (500 mg), vitamin E (400 IU), lutein (10 mg), zeaxanthin (2 mg), zinc (80 mg) and copper (2 mg) can modestly reduce progression of AMD (primarily dry form) and may complement anti‑VEGF therapy.[8]
  • Control systemic hypertension, hyperlipidemia, and diabetes.
  • Smoking cessation and weight management.

Living with Exudative Macular Degeneration

Even with treatment, many patients experience some visual impairment. The following strategies help maintain independence and quality of life.

Vision Rehabilitation

  • Low‑vision aids: magnifiers, high‑contrast reading glasses, electronic CCTV readers.
  • Adaptive technologies: screen‑reading software (JAWS, VoiceOver), smartphone accessibility features, and voice‑controlled assistants.
  • Orientation & mobility training for safe navigation.

Daily Practical Tips

  • Use **good lighting**—prefer daytime or bright LED lamps; avoid glare.
  • Position reading material **directly below eye level** to use residual peripheral vision.
  • Mark household items (e.g., stove knobs, medication bottles) with **high‑contrast stickers**.
  • Adopt a **consistent routine**—place items in the same spot to rely on muscle memory.
  • Consider a **guide dog or cane** if peripheral vision is also compromised.

Follow‑up Care

Anti‑VEGF regimens typically require **monthly or bimonthly visits** initially. Bring a list of all medications, and report any new symptoms (e.g., increased floaters, sudden dark spots).

Prevention

While age cannot be changed, modifying modifiable risk factors can lower the likelihood of developing wet AMD or slow its progression.

  • Quit smoking – seek counseling, nicotine replacement, or prescription aid.
  • Adopt a Mediterranean‑style diet rich in leafy greens, fish, nuts, and olive oil; these foods provide antioxidants and omega‑3 fatty acids that support retinal health.
  • Wear **UV‑blocking sunglasses** (≥99 % UVA/UVB protection) whenever outdoors.
  • Maintain **blood pressure and cholesterol** within target ranges; regular primary‑care check‑ups.
  • Engage in regular **moderate aerobic exercise** (≥150 min/week) to improve circulation.
  • Consider **AREDS2 supplements** after discussing with an eye care professional, especially if you have early or intermediate AMD.

Complications

If untreated or inadequately treated, wet AMD can lead to serious sequelae.

  • Permanent central vision loss – irreversible scarring of the macula.
  • Choroidal neovascular membrane (CNVM) fibrosis – dense scar that further impairs visual acuity.
  • Macular hemorrhage – large bleed may cause sudden, profound vision loss.
  • Increased risk of retinal detachment – rare but possible after extensive laser or surgery.
  • Psychological impact – depression, anxiety, and reduced independence are common; early referral to counseling or support groups is advisable.

When to Seek Emergency Care

Urgent warning signs that require immediate evaluation (within hours):
  • Sudden appearance of a dark spot or “shadow” in the center of vision.
  • Rapid increase in the number or size of floaters, especially if accompanied by flashes of light.
  • Sudden loss of vision in one eye.
  • Severe eye pain, redness, or a feeling of pressure.

If any of these occur, go to the nearest emergency department or call your eye‑care provider right away. Prompt treatment can preserve vision.

References

  1. Mayo Clinic. “Age‑related macular degeneration.” Updated 2023.
  2. Cleveland Clinic. “Wet macular degeneration.” Accessed 2024.
  3. National Eye Institute (NEI). “Age‑Related Macular Degeneration Statistics.” 2022.
  4. World Health Organization. “Global Vision Impairment and Blindness.” 2021.
  5. U.S. National Library of Medicine. “Genetic risk factors for AMD.” 2023.
  6. Centers for Disease Control and Prevention. “Smoking and eye disease.” 2022.
  7. J. Ophthalmol. “Efficacy of anti‑VEGF agents in wet AMD: a meta‑analysis.” 2023.
  8. AREDS2 Research Group. “Nutritional supplementation for AMD.” JAMA Ophthalmology. 2021.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References